News

Chip on your shoulder?

Here’s how having a clear understanding of the services different crisis stabilization units provide can help communities serve the unique needs of each individual in crisis without unnecessarily restrictive or intensive levels of care.

When considering transcranial magnetic stimulation as a treatment option for treatment-resistant depression, here are some key questions to ask the patient.

A mayday call to support maternal mental health.

First of its kind culturally sensitive adherence scale factors in CVD risk factors to find ways to best support patients.

What is wisdom, and how is it connected to age?

When the Surgeon General notices the loneliness problem, it is definitely a mayday moment.

The risperidone formulation is the first FDA-approved treatment for this patient population to use technology enabling controlled release over time.

Treatment is now the first and only once-at-bedtime oxybate to be approved by the FDA for individuals with narcolepsy.

What lessons can we learn from May Day, mayday, and rejection?

May is Mental Health Month!

The experts weighed in on a wide variety of psychiatric issues for the April 2023 issue of Psychiatric Times.

"life, liberty, and happiness pursue survival hanging in the distance..."

From connections between bvFTD and primary psychiatric disorders to the impact of posttraumatic neuroendocrine dysfunction on recovery, here are highlights from the week in Psychiatric Times.

Always remember to think positive!

Aripiprazole will be the first 2-month LAI antipsychotic indicated for both the treatment of schizophrenia and the maintenance treatment of bipolar I disorder in the United States.

"And I believe that the current state of America is seeing rivers of red minus the white and blue..."

Can we find a new and expanded kind of community psychiatry?

A psychiatrist reflects on trivial times...

Social prescribing was rolled out in 2019 as 1 of the 6 core pillars of a comprehensive model of personalized patient care.

The story of the legendary Beat poet’s involvement with madness and mental illness has never really been told—until now.

Ulotaront, a trace amine-associated receptor 1 agonist with 5-HT1A agonist activity, is under investigation for the treatment of generalized anxiety disorder.

Traumatic brain injury-induced dysregulation of the neuroendocrine system and may contribute to the exacerbation of posttraumatic morbidity.

May is Mental Health Month!

Prescribing the arts for better mental health…

In this CME, learn more about frontotemporal lobar degeneration and the several overlapping syndromes that it encompasses, as well as how to distinguish behavioral variant frontotemporal lobar degeneration from other psychiatric disorders.

Social psychiatry is embedded in the practice at large.

From eating disorders in entertainment to early intervention for schizophrenia, here are highlights from the week in Psychiatric Times.

A logical assessment...